461 Mrv1909 05171921032D 18 19 0 0 0 0 999 V2000 2.3633 -1.2429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.1330 1.2516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.9897 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7041 0.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5608 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5608 -0.8105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2754 0.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4183 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9897 -0.8105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2754 -1.2230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8235 0.4552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8235 -1.2516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0760 -0.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0760 0.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.1330 0.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.8472 0.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6473 -0.8332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4183 -0.8103 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 13 1 0 0 0 0 1 17 1 0 0 0 0 2 15 1 0 0 0 0 3 4 1 0 0 0 0 3 7 2 0 0 0 0 3 9 1 0 0 0 0 4 8 1 0 0 0 0 5 6 2 0 0 0 0 5 7 1 0 0 0 0 5 11 1 0 0 0 0 6 10 1 0 0 0 0 6 12 1 0 0 0 0 8 15 1 0 0 0 0 9 10 2 0 0 0 0 11 14 2 0 0 0 0 12 13 2 0 0 0 0 13 14 1 0 0 0 0 15 16 1 0 0 0 0 8 18 1 0 0 0 0 M END > DBMET02530 > drugbank > COC1=CC2=C(C=C1)C=C(CC(O)C(C)O)C=C2 > InChI=1S/C15H18O3/c1-10(16)15(17)8-11-3-4-13-9-14(18-2)6-5-12(13)7-11/h3-7,9-10,15-17H,8H2,1-2H3 > MCZLAGYGEYMZAQ-UHFFFAOYSA-N > C15H18O3 > 246.306 > 246.12559444 > 3 > 36 > 27.646079158530245 > 1 > 2 > 0 > 1 > 1-(6-methoxynaphthalen-2-yl)butane-2,3-diol > 2.23 > 2.1126028273333333 > -3.20 > 0 > 2 > 0 > 15.501203998600534 > 13.95629482327817 > -3.015222307454822 > 49.69 > 70.92360000000001 > 4 > 1 > 1.56e-01 g/l > (1S,2R,3S,4S)-2,3,4,5-tetrahydroxy-6-({[2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-yl]oxy}methyl)cyclohexane-1-carboxylic acid > 0 > DBMET02530 > reduced 3-hydroxy-nabumetone $$$$